Comparison of Lichtenstein with Desarda Repair in Patients with Inguinal Hernia
DOI:
https://doi.org/10.52206/jsmc.2022.12.1.705Abstract
Background: Chronic groin pain is a common complaint after repair of inguinal hernia. Its frequently due to iatrogenic damage or
entrapment of the nerves, in and around the inguinal canal, the most important of which is the ilioinguinal nerve. This study will help
us give local evidence successful inguinal hernia treatment without mesh implantation if our study support it and we will come to
know about the potential benefits of both these procedures and its suitability in our local population which needs further evaluation.
Objective: To compare Lichtenstein repair with Desarda repair in Inguinal hernia in term of post-operative pain.
Material and Methods: This Randomized control trial study over 186 patients, having inguinal hernia presenting to the Outpatients
department/Emergency Response using convenience sampling. Patients were randomly divided into two groups. The postth operative pain was assessed at 7 day after surgery, using visual analogue scale.
Results: The study was carried out on 186 patients, divided into two surgical groups. At 7 day interval, patients having mild,
moderate and severe pain were 71 (76.3%), 20(21.5%) and 2 (2.2%) respectively for Desarda Group while 65(69.9%), 20(21.5%)
and 5(5.4%) respectively for Lichtenstein repair. But this was statistically insignificant with p-value=0.415.
Conclusion: Desarda inguinal hernia repair is effective in decreasing the incidence of chronic groin pain in comparison with
Lichtenstein mesh hernioplasty but have no significant difference.
Key words: Inguinal Hernia, Desarda, Lichtenstein Repair, Pain.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2022 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.